The 4th JCA-AACR Special Joint Conference
Schedule Download
Instructions for Oral presenters（90KB）
Instructions for Poster presenters（94KB）
The Latest Advances in Gastric Cancer Research:
From Basic Science to Therapeutics
December 16(Mon.)-18(Wed.), 2013
Tokyo Bay Maihama Hotel Club & Resorts (Maihama, Urayasu-shi, Chiba)
( former"TOKYO BAY HOTEL TOKYU")
1-7, Maihama, Urayasu-shi, Chiba 279-0031
TEL: 047-355-2411
http://www.tbm-clubresort.jp/eng/
演題募集・参加登録は締切りました。
たくさんのご応募を頂きありがとうございました。
- JCA committee member: (http://www.jca.gr.jp/)
- Masanori Hatakeyama (Univ. Tokyo)
Atsushi Ohtsu（National Cancer Center）
Wataru Yasui（Hiroshima Univ.） - AACR committee member：(http://www.aacr.org/)
- Timothy C. Wang (Columbia Univ. Medical Center)
James G. Fox (Massachusetts Institute of Technology)
James R. Goldenring (Vanderbilt Univ.)
Program (tentative)
Speakers are listed in alphabetical order by last name within each session
Dec. 16
| Welcome address(18:00-18:10) | |||
| Session | Speaker (tentative) | Title | |
|---|---|---|---|
| Keynote lectures (18:10-19:30) |
Dr. Masanori HATAKEYAMA (Univ. Tokyo) |
Helicobacter pylori oncoprotein CagA | |
| Dr.Timothy C. WANG (Columbia Univ. Medical Center ) |
Gastric stem cells and the origins of diffuse gastric cancer | ||
Dec. 17
| Session | Speaker (tentative) | Title | |
|---|---|---|---|
| 1 | Helicobacter pylori (8:30-10:00) |
Dr. Tsutomu CHIBA (Kyoto Univ.) |
Mechanism for induction of genetic aberration during inflammation-associated gastric carcinogenesis by H. pylori infection |
| Dr. James G. FOX (MIT) |
The gastrointestinal microbiome: its role in H. pylori associated gastric cancer | ||
| Dr. Koichi MATSUDA (Univ. Tokyo) |
GWAS of diseases related with Helicobacter pylori infection | ||
| 2 | Inflammation/tumor microenvironment (10:20-11:50) |
Dr. Masashi FUKAYAMA (Univ. Tokyo) |
Viral microRNA in EB virus-associated gastric carcinoma |
| Dr. Andy GIRAUD (Murdoch Childrens Res. Inst.) |
Gastric atrophy:cytokine privet strategies for blocking progression to cancer | ||
| Dr. Masanobu OSHIMA (Kanazawa Univ.) |
Chronic inflammation in tumor development and invasion | ||
| Lunch and poster view(11:50-12:50) | |||
| Poster presentation(12:50-14:20) | |||
| 3 | Epigenetics & genetics and cancer genomics (14:20-16:20) |
Dr. Adam J. BASS (Dana-Farber Cancer Inst.) |
Genomics of gastric cancer |
| Dr. Hiromi SAKAMOTO (National Cancer Center) |
Towards the genetics and genomics of diffuse gastric cancer | ||
| Dr. Shu SHIMADA (Tokyo Medical and Dental Univ.) |
Targeting epigenetic alterations in a mouse model of E-cadherin/p53-deficient diffuse-type gastric cancer | ||
| Dr. Toshikazu USHIJIMA (National Cancer Center) |
Epigenetic and genetic alterations in gastric cancers and their origins | ||
| 4 | Pathology and biomarkers (16:40-17:40) |
Dr. Emad EL-OMAR (Aberdeen Univ.) |
Host genetics of gastric cancer |
| Dr. James R. GOLDENRING (Vanderbilt Univ.) |
Insights into the origins of preneoplastic metaplasia in the stomach | ||
| Meet-the expert evening (all participants) (18:00-19:00) | |||
Dec. 18
| Session | Speaker (tentative) | Title | |
|---|---|---|---|
| 4 | Pathology and biomarkers (8:00-10:00) |
Dr. Juanita L. MERCHANT (Univ. Michigan) |
Identifying candidate mouse genes to inform biomarker development for gastric cancer |
| Dr. Atsushi OCHIAI (National Cancer Center) |
Evaluation of molecular targets and innovation of indivisualized diagnosis of the gastric cancer | ||
| Dr. Masakazu YASHIRO (Osaka City Univ.) |
Molecular mechanisms responsible for scirrhous gastric cancer and novel targeting therapies | ||
| Dr. Wataru YASUI (Hiroshima Univ.) |
Novel biomarkers and therapeutic targets for gastric cancer | ||
| 5 | Cancer stem cells (10:20-11:50) |
Dr. Hideshi ISHII (Osaka Univ.) |
Innovative medical treatment for intractable cancer stem cells |
| Dr. Yoshiaki ITO (National Univ. Singapore) |
Characterization of epithelial stem/progenitor cells of stomach corpus |
||
| Dr. Linda C. SAMUELSON (Univ. Michigan) |
Notch pathway regulation of gastric stem cell | ||
| Lunch and Poster View(11:50-12:50) | |||
| 5 | Cancer stem cells (12:50-13:50) |
Dr. Hideyuki SAYA (Keio Univ.) |
Role of CD44v in gastric cancer stem cells |
| Dr. Hidekazu SUZUKI (Keio Univ.) |
Crosstalk between gastric cancer stem cell and Helicobacter pylori | ||
| 6 | New anticancer agents (13:50-16:10) |
Dr.Duan CHEN (NTNU) |
Novel strategy for control of gastric cancer: surgical or pharmacological denervation |
| Dr. Toshihiko DOI (National Cancer Center) |
Current status of new agent for advanced gastric cancer | ||
| Dr. Takako NAKAJIMA (St. Marianna Univ. Sch. Med.) |
Perspective of chemotherapy for gastric cancer | ||
| Dr. Atsushi OHTSU (National Cancer Center) |
Overview of new molecular targeting agents under development for gastric cancer | ||
| Closing remarks | |||